Chronos Archive seal
The Human Record

Zelda Fitzgerald

Case HR-ET004 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
July 24, 1900 – March 10, 1948
Synthetic DOB
1996-07-24
Index visit
2026-05-11 at age 29
Synthetic MRN
HR-ET004-SYN

Teaching objective: Dignified, recovery-oriented primary care for a 29-year-old dancer and writer twelve days after a first psychiatric admission for psychosis with marked manic and depressive symptoms: holding the diagnosis provisional (bipolar I disorder with psychotic features, schizoaffective disorder, or schizophreniform disorder or schizophrenia) and showing how the course settles it; lithium with level, kidney, thyroid and calcium monitoring and sick-day rules learned from a lithium level above range during gastroenteritis; antipsychotic metabolic and prolactin monitoring, with a switch from risperidone to aripiprazole when raised prolactin and amenorrhea persisted; reproductive health on teratogenic medicines (valproate avoided, contraception and folic acid); an eating and exercise screen for a dancer with low weight and missed periods; coordinated specialty care; and a structured safety assessment with lethal-means counseling and the 988 Suicide & Crisis Lifeline reviewed at every visit, on the CANMAT and ISBD bipolar guidelines, the APA 2020 schizophrenia guideline, and the CMID depression and bipolar monograph.

Historical timeline

DateEventClaims
July 24, 1900Born in Montgomery, Alabama.CLM-0001
April 3, 1920Married in New York.CLM-0002
about 1927Began ballet training with Lubov Egorova, almost eight hours a day.CLM-0003
1930First breakdown; hospitalized for nervous exhaustion.CLM-0004
June 1930Admitted to Les Rives de Prangins, Nyon; treated for schizophrenia until September 1931.CLM-0005
February 1932Entered the Phipps Clinic, Johns Hopkins.CLM-0006
May 1934Returned to Sheppard Pratt from Craig House.CLM-0007
April 1936Moved to Highland Hospital, Asheville.CLM-0008
March 10, 1948Died in a fire at Highland Hospital.CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Zelda Sayre was born on July 24, 1900, in Montgomery, Alabama, the youngest child of Alabama Supreme Court Justice Anthony Dickson Sayre and Minnie Buckner Machen Sayre; as a girl she starred in ballet recitals. confirmed Curnutt K. Zelda Sayre Fitzgerald supports
HISTMED Master Roster v3 context
D In July 1918 she met F. Scott Fitzgerald; they married in New York on April 3, 1920, and their only child, Frances "Scottie" Fitzgerald, was born in 1921.
Family history as context only; the modern episode gives no role to her husband or daughter.
confirmed Curnutt K. Zelda Sayre Fitzgerald supports
McKown HW Jr. The Death of Zelda Fitzgerald supports
D In the late 1920s she returned to dance. She began ballet lessons at 27 with Lubov Egorova, hoping to dance with the Ballets Russes, and took classes every morning and afternoon, practising for almost eight hours a day.
The anchor for the modern dance training, the eating and exercise screen, and the amenorrhea.
confirmed Save me a dance supports
Curnutt K. Zelda Sayre Fitzgerald supports
Zelda Sayre Fitzgerald (artist biography) supports
D In 1930 the stress of her frustrated attempts to become a professional ballerina led to the first of many breakdowns. On a trip to Europe that year she was hospitalized for nervous exhaustion.
The anchor for the synthetic first episode of psychosis and its index age.
confirmed Curnutt K. Zelda Sayre Fitzgerald supports
Zelda Sayre Fitzgerald (artist biography) supports
D From June 1930 to September 1931 she lived at the Les Rives de Prangins clinic in Nyon, Switzerland, where she was treated for schizophrenia; her main physician was Dr. Oscar Forel. She was diagnosed as schizophrenic in 1930 and gave up ballet.
After the index date; recorded as history.
confirmed Curnutt K. Zelda Sayre Fitzgerald supports
Zelda Sayre Fitzgerald (artist biography) supports
Save me a dance supports
D In February 1932 she entered the Phipps Clinic of Johns Hopkins University, where she completed her only novel, Save Me the Waltz.
After the index date; her writing in hospital is recorded as a strength.
confirmed Curnutt K. Zelda Sayre Fitzgerald supports
Save me a dance supports
D By 1934 she was spending her weekdays in the Sheppard and Enoch Pratt Hospital in Towson, Maryland. After a brief period of wellness her illness worsened; she was moved to Craig House in New York and returned to Sheppard Pratt in May 1934.
After the index date; recorded as history.
confirmed Dennies N. F. Scott Fitzgerald at 1307 Park Avenue supports
Zelda Sayre Fitzgerald (artist biography) supports
D In April 1936 she moved to Highland Hospital in Asheville, North Carolina, where she lived until 1940; afterwards she returned there at times when depression became debilitating, and her stays were intermittent until her death.
After the index date; recorded as history.
confirmed Dennies N. F. Scott Fitzgerald at 1307 Park Avenue supports
Curnutt K. Zelda Sayre Fitzgerald supports
Highland Hospital: timeline supports
D She wrote and painted throughout her life; a 1934 exhibition in New York showed her paintings and drawings.
Her creative work is recorded as a strength.
confirmed Curnutt K. Zelda Sayre Fitzgerald supports
Zelda Sayre Fitzgerald (artist biography) supports
D Late on the night of March 10, 1948, a fire that started in a kitchen of the main building of Highland Hospital spread through the building; nine patients died, among them Zelda Fitzgerald.
History only, recorded without detail. One source dates the fire to the night of March 10 to 11.
confirmed McKown HW Jr. The Death of Zelda Fitzgerald supports
Curnutt K. Zelda Sayre Fitzgerald supports
R Although she was treated for schizophrenia, mental-health experts later contested both the diagnosis and the treatment prescribed by her main physician.
Retrospective; the reason the modern diagnosis begins as provisional.
disputed Curnutt K. Zelda Sayre Fitzgerald supports
R A psychiatrist writing to the Princeton Alumni Weekly argued that her history of remissions and exacerbations makes schizophrenia highly unlikely and bipolar illness more likely.
Retrospective opinion in a reader's letter; puts bipolar I disorder first in the modern differential.
possible Conroy RC. Zelda (letter) supports
R The psychiatrist Mary Seeman, drawing on biographies, describes her illness as showing specific precipitants, discontinuities in its course, pronounced mood swings, preserved intellect and agency, and flare-ups associated with immune and hormonal changes, as an example of how psychosis can present in women.
Retrospective interpretation; supports attention to mood, hormonal change and course in the modern episode.
possible Seeman MV. Gendering psychosis: the illness of Zelda Fitzgerald. Med Humanit. 2016;42(1):65-69 (PMID 26392268) supports
R Her ballet training has been described as an obsession bordering on mania. The project roster reads it as an exercise compulsion with an eating disorder, an interpretation that no fetched clinical source makes.
Retrospective; the reason the modern episode screens for disordered eating and compulsive exercise without assuming either.
possible Save me a dance supports
HISTMED Master Roster v3 context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S First episode of psychosis with marked mood symptoms: about three weeks of little sleep, rapid speech, racing thoughts, grandiose plans and very long training days, then a voice commenting on her dancing and a belief that she was being watched and tested; tearful low mood since discharge. Diagnosis provisional; differential: bipolar I disorder with psychotic features, schizoaffective disorder (bipolar type), and schizophreniform disorder or schizophrenia, depending on whether the psychosis ever occurred apart from the mood symptoms. Synthetic modern episode linked to her documented first hospitalization resolved provisional both_with_link CLM-0004, CLM-0011, CLM-0012, CLM-0013
S Bipolar I disorder, most recent episode manic with psychotic features, in full remission: the working diagnosis at three months, when her history, her journal, and her roommate's account (given with her consent) showed that the voice and the belief she was watched began only after weeks of manic symptoms and ended with them, with no psychosis since. Remains provisional: it would be revised to schizoaffective disorder if psychosis ever lasted two weeks or more without a mood episode. Synthetic modern episode linked to the documented breakdown and its retrospective interpretations active provisional both_with_link CLM-0004, CLM-0011, CLM-0012, CLM-0013
S Secondary amenorrhea: no periods for about four months before admission, during very heavy dance training at a low weight (BMI 18.7), with prolactin raised on risperidone; pregnancy test negative resolved confirmed active CLM-0003, CLM-0014
S Acute viral gastroenteritis (vomiting and watery diarrhea for two days, roommate with the same illness), with mild dehydration; resolved resolved confirmed active
S Lithium level above the therapeutic range (1.4 mmol/L) during dehydration, with nausea and a worse fine tremor, without confusion or unsteadiness; lithium held and restarted; resolved resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-05-11 Leukocytes [#/volume] in Blood by Automated count 6.1 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-05-11 Hemoglobin [Mass/volume] in Blood 12.6 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-05-11 Platelets [#/volume] in Blood by Automated count 248 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-05-11 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-05-11 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-11 Creatinine [Mass/volume] in Serum or Plasma 0.72 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-05-11 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 116 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-11 Glucose [Mass/volume] in Serum or Plasma 84 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-05-11 Calcium [Mass/volume] in Serum or Plasma 9.4 mg/dL
Reference 8.6-10.2 mg/dL
http://loinc.org · 17861-6
S 2026-05-11 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-05-11 Prolactin [Mass/volume] in Serum or Plasma 62 ng/mL (high)
Reference 4.8-23.3 ng/mL
http://loinc.org · 2842-3
S 2026-05-11 Hemoglobin A1c/Hemoglobin.total in Blood 5%
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes
http://loinc.org · 4548-4
S 2026-05-11 Cholesterol [Mass/volume] in Serum or Plasma 168 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-05-11 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 90 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2026-05-11 Cholesterol in HDL [Mass/volume] in Serum or Plasma 64 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-05-11 Triglyceride [Mass/volume] in Serum or Plasma 70 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-05-11 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 11 http://loinc.org · 44261-6
S 2026-05-11 Total score [AUDIT-C] 2 http://loinc.org · 75626-2
S 2026-05-18 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 9 http://loinc.org · 44261-6
S 2026-06-01 Sodium [Moles/volume] in Serum or Plasma 134 mmol/L (low)
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-06-01 Potassium [Moles/volume] in Serum or Plasma 3.4 mmol/L (low)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-01 Creatinine [Mass/volume] in Serum or Plasma 1.08 mg/dL (high)
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-06-01 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 71 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-06-01 Glucose [Mass/volume] in Serum or Plasma 80 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-06-01 Lithium [Moles/volume] in Serum or Plasma 1.4 mmol/L (high)
Reference Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range
http://loinc.org · 14334-7
S 2026-06-08 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-06-08 Potassium [Moles/volume] in Serum or Plasma 4.1 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-06-08 Creatinine [Mass/volume] in Serum or Plasma 0.78 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-06-08 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 105 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-06-08 Lithium [Moles/volume] in Serum or Plasma 0.8 mmol/L
Reference Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range
http://loinc.org · 14334-7
S 2026-06-08 Prolactin [Mass/volume] in Serum or Plasma 66 ng/mL (high)
Reference 4.8-23.3 ng/mL
http://loinc.org · 2842-3
S 2026-06-08 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-08-10 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-08-10 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-08-10 Creatinine [Mass/volume] in Serum or Plasma 0.8 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-08-10 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 102 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-08-10 Lithium [Moles/volume] in Serum or Plasma 0.74 mmol/L
Reference Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range
http://loinc.org · 14334-7
S 2026-08-10 Thyrotropin [Units/volume] in Serum or Plasma 2.9 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-08-10 Calcium [Mass/volume] in Serum or Plasma 9.6 mg/dL
Reference 8.6-10.2 mg/dL
http://loinc.org · 17861-6
S 2026-08-10 Prolactin [Mass/volume] in Serum or Plasma 14 ng/mL
Reference 4.8-23.3 ng/mL
http://loinc.org · 2842-3
S 2026-08-10 Fasting glucose [Mass/volume] in Serum or Plasma 86 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 1558-6
S 2026-08-10 Hemoglobin A1c/Hemoglobin.total in Blood 5.1%
Reference Below 5.7% is normal; 5.7 to 6.4% prediabetes
http://loinc.org · 4548-4
S 2026-08-10 Cholesterol [Mass/volume] in Serum or Plasma 174 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-08-10 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 94 mg/dL
Reference <=129 mg/dL
http://loinc.org · 13457-7
S 2026-08-10 Cholesterol in HDL [Mass/volume] in Serum or Plasma 62 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-08-10 Triglyceride [Mass/volume] in Serum or Plasma 82 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-08-10 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 http://loinc.org · 44261-6
S 2026-10-26 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-10-26 Potassium [Moles/volume] in Serum or Plasma 4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-10-26 Creatinine [Mass/volume] in Serum or Plasma 0.79 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-10-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 103 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-10-26 Lithium [Moles/volume] in Serum or Plasma 0.72 mmol/L
Reference Maintenance target 0.6 to 0.8 mmol/L; above 1.2 mmol/L is above the therapeutic range
http://loinc.org · 14334-7
S 2026-10-26 Thyrotropin [Units/volume] in Serum or Plasma 3.1 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 2026-10-26 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2026-09-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2026-09-14 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-05-11Body height165 cm8302-2S
2026-05-11Body weight50.8 kg29463-7S
2026-05-11Body mass index (BMI) [Ratio]18.7 kg/m239156-5S
2026-05-11Systolic blood pressure108 mm[Hg]8480-6S
2026-05-11Diastolic blood pressure68 mm[Hg]8462-4S
2026-05-11Heart rate78 /min8867-4S
2026-05-11Respiratory rate14 /min9279-1S
2026-05-11Body temperature36.6 Cel8310-5S
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-05-18Body height165 cm8302-2S
2026-05-18Body weight51 kg29463-7S
2026-05-18Body mass index (BMI) [Ratio]18.7 kg/m239156-5S
2026-05-18Systolic blood pressure106 mm[Hg]8480-6S
2026-05-18Diastolic blood pressure66 mm[Hg]8462-4S
2026-05-18Heart rate76 /min8867-4S
2026-05-18Respiratory rate14 /min9279-1S
2026-05-18Body temperature36.5 Cel8310-5S
2026-05-18Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-06-08Body height165 cm8302-2S
2026-06-08Body weight50.2 kg29463-7S
2026-06-08Body mass index (BMI) [Ratio]18.4 kg/m239156-5S
2026-06-08Systolic blood pressure104 mm[Hg]8480-6S
2026-06-08Diastolic blood pressure66 mm[Hg]8462-4S
2026-06-08Heart rate74 /min8867-4S
2026-06-08Respiratory rate14 /min9279-1S
2026-06-08Body temperature36.6 Cel8310-5S
2026-06-08Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-08-10Body height165 cm8302-2S
2026-08-10Body weight51.6 kg29463-7S
2026-08-10Body mass index (BMI) [Ratio]19 kg/m239156-5S
2026-08-10Systolic blood pressure108 mm[Hg]8480-6S
2026-08-10Diastolic blood pressure68 mm[Hg]8462-4S
2026-08-10Heart rate70 /min8867-4S
2026-08-10Respiratory rate14 /min9279-1S
2026-08-10Body temperature36.6 Cel8310-5S
2026-08-10Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-10-26Body height165 cm8302-2S
2026-10-26Body weight52.4 kg29463-7S
2026-10-26Body mass index (BMI) [Ratio]19.2 kg/m239156-5S
2026-10-26Systolic blood pressure110 mm[Hg]8480-6S
2026-10-26Diastolic blood pressure70 mm[Hg]8462-4S
2026-10-26Heart rate68 /min8867-4S
2026-10-26Respiratory rate14 /min9279-1S
2026-10-26Body temperature36.5 Cel8310-5S
2026-10-26Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-06-01Body height165 cm8302-2S
2026-06-01Body weight49.6 kg29463-7S
2026-06-01Body mass index (BMI) [Ratio]18.2 kg/m239156-5S
2026-06-01Systolic blood pressure102 mm[Hg]8480-6S
2026-06-01Diastolic blood pressure64 mm[Hg]8462-4S
2026-06-01Heart rate104 /min8867-4S
2026-06-01Respiratory rate16 /min9279-1S
2026-06-01Body temperature37.7 Cel8310-5S
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-14Body height165 cm8302-2S
2026-09-14Body weight51.9 kg29463-7S
2026-09-14Body mass index (BMI) [Ratio]19.1 kg/m239156-5S
2026-09-14Systolic blood pressure108 mm[Hg]8480-6S
2026-09-14Diastolic blood pressure68 mm[Hg]8462-4S
2026-09-14Heart rate68 /min8867-4S
2026-09-14Respiratory rate14 /min9279-1S
2026-09-14Body temperature36.6 Cel8310-5S
2026-09-14Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Structured safety assessment

Current ideation
absent
Intent
absent
Plan
absent
Disposition
Outpatient care with close follow-up. She has no thoughts of suicide or self-harm now and had none during the admission. Her risk is higher in the months after a first episode, and especially in a depressive phase after mania, so a written safety plan was made with her, with her own early warning signs (sleeping less, training for hours, racing thoughts, or feeling hopeless) and what to do about each. Lethal-means counseling: she has no firearm and no access to one; any medicine that is dangerous in overdose will be dispensed in small amounts while her mood is low. The 988 Suicide & Crisis Lifeline was given and saved in her phone, with the clinic number. Safety reviewed at every visit

This assessment is synthetic and does not convert historical behavior into a present-day fact.

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
No manic, depressive or psychotic episode and no readmission through six months2026-10-26completedNo episode and no admission; lithium and aripiprazole continued
Lithium trough level 0.6 to 0.8 mmol/L with normal kidney and thyroid tests at six months2026-10-26completedLithium 0.72 mmol/L; creatinine 0.79 mg/dL; TSH 3.1 mIU/L
Periods return and prolactin is normal by three months2026-08-10completedPeriods returned five weeks after the switch to aripiprazole; prolactin 14 ng/mL
BMI at least 19, with food matched to her training, by six months2026-10-26completedBMI 19.2 at 52.4 kg, dancing about four hours a day
PHQ-9 score below 5 by six months2026-10-26completedPHQ-9 3

Interventions

InterventionStatusGuideline
Continue the antipsychotic started in hospital, with monitoring to the APA and ADA/APA standard: weight at every visit, blood pressure, fasting glucose or A1c and lipids at baseline, 12 weeks and yearly, prolactin because her periods have stopped, side-effect checks, and the AIMS at baseline and every six monthscompletedGL-APA-SCZ-2020, GL-ADA-APA-2004, GL-CMID-2026
Psychiatry consultation with the first-episode psychosis coordinated specialty care team on the provisional diagnosis and how to settle it, a mood stabilizer to prevent another episode, and the antipsychotic choice given her raised prolactin and missed periodscompletedGL-CANMAT-BD-2018, GL-APA-SCZ-2020, GL-NIMH-CSC
Reproductive health on psychiatric medicines: a pregnancy test before any new medicine, valproate avoided because of its risks in pregnancy, counseling on the risks of any mood stabilizer in pregnancy, contraception that suits her, folic acid, and planning with psychiatry before any pregnancycompletedGL-CANMAT-BD-2018, GL-CDC-SPR-2024
Eating and exercise: the SCOFF screen, menstrual and energy review at each visit, a sports dietitian, and a graded return to dance with food matched to the training load; training hours watched as an early warning signcompletedGL-APA-SCZ-2020, GL-CANMAT-BD-2018
Coordinated specialty care: a care coordinator, individual therapy with psychoeducation about mood and psychosis, education for the people she chooses, support to return to dance and writing, and a peer specialistcompletedGL-NIMH-CSC, GL-APA-SCZ-2020
Sleep and early warning signs: regular sleep and wake times, no all-night writing or training, and a plan to call the team after two short nights or if training hours climbcompletedGL-CANMAT-BD-2018
Lithium carbonate 300 mg twice daily after a negative pregnancy test, with 12-hour trough levels 5 to 7 days after starting and after any change, then every 3 to 6 months (target 0.6 to 0.8 mmol/L); creatinine and eGFR every 2 to 3 months for 6 months, then every 6 to 12; TSH once or twice in the first 6 months, then every 6 to 12; calcium yearly; and sick-day rules: hold it during vomiting, diarrhea or dehydration, and avoid anti-inflammatory painkillerscompletedGL-CANMAT-BD-2018, GL-CANMAT-BD-2023, GL-CMID-2026
Switch from risperidone to aripiprazole: aripiprazole 10 mg daily with risperidone 1 mg for one week, then risperidone stopped; prolactin and periods checked at three monthscompletedGL-APA-SCZ-2020, GL-CANMAT-BD-2018
Structured safety assessment, a written safety plan with early warning signs, lethal-means counseling, the 988 Suicide & Crisis Lifeline, the PHQ-9 at each visit, and safety review at every visitcompletedGL-SUICIDE-2024, GL-CMID-2026, GL-USPSTF-DEP-2023
Lithium sick-day plan, written down and shared with her roommate with her consent: stop lithium during vomiting, diarrhea, fever with poor drinking, or heavy sweating without fluids, and call the clinic; restart when eating and drinking normally; no anti-inflammatory painkillers; and go to the emergency department for confusion, unsteadiness, slurred speech, or a coarse tremorcompletedGL-CANMAT-BD-2018, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Curnutt K. Zelda Sayre Fitzgerald Encyclopedia of Alabama (Alabama Humanities Alliance; Troy University Montgomery) biography
SRC-0002 McKown HW Jr. The Death of Zelda Fitzgerald NCpedia (State Library of North Carolina), This Month in North Carolina History biography
SRC-0003 Zelda Sayre Fitzgerald (artist biography) Asheville Art Museum other
SRC-0004 Dennies N. F. Scott Fitzgerald at 1307 Park Avenue Explore Baltimore Heritage other
SRC-0005 Highland Hospital: timeline Duke University Medical Center Library and Archives other
SRC-0006 Seeman MV. Gendering psychosis: the illness of Zelda Fitzgerald. Med Humanit. 2016;42(1):65-69 (PMID 26392268) Medical Humanities (BMJ) scholarly
SRC-0007 Conroy RC. Zelda (letter) Princeton Alumni Weekly, Inbox other
SRC-0008 Save me a dance The Australian Ballet (blog) other
SRC-0009 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the provisional coding and its revision to bipolar I disorder at three months, the lithium dosing and the outpatient management of a level of 1.4 mmol/L with dehydration, the risperidone-to-aripiprazole switch for raised prolactin, and the reproductive health counseling.
provenance reviewnot_startedEncyclopedia of Alabama, NCpedia, the Asheville Art Museum, Explore Baltimore Heritage, the Duke Medical Center archives, Seeman 2016 (abstract), a Princeton Alumni Weekly letter, and the Australian Ballet logged. Retrospective diagnoses are graded R with their certainty; the roster's eating-disorder reading is recorded as unsupported by a clinical source.
safe messaging reviewnot_startedMental-health, eating and exercise claims are marked sensitive; the long hospitalizations are recorded factually; her death in a hospital fire is recorded as history without detail; the safety assessment records no ideation, gives lethal-means counseling and the 988 Suicide & Crisis Lifeline, and safety is reviewed at every visit.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.